Abstract
The need for maintenance digoxin treatment was assessed in a double-blind, variable-dose, crossover comparison with placebo. Forty-six outpatients who had been prescribed the drug for heart failure were studied; 33 were in sinus rhythm and the remainder in atrial fibrillation. Mean serum digoxin concentrations in those with sinus rhythm averaged 1-33 nmol/l, but a lower concentration, averaging 0-97 nmol/l, was accepted in those with atrial fibrillation as six of them developed bradycardia. Sixteen of the 46 patients deteriorated on placebo, and eight completely recovered when digoxin was reintroduced; in the remainder additional diuretics were required temporarily. Spirometric values deteriorated on changing to placebo whether or not the patient showed clinical evidence of recurrence of heart failure. In a separate study of nine patients who showed no clinical evidence of deterioration on placebo, reintroduction of digoxin caused a shortening of left ventricular ejection time, which persisted for at least a month. This suggests that the inotropic response to digoxin is sustained during maintenance treatment.
Full text
PDF
Selected References
These references are in PubMed. This may not be the complete list of references from this article.
- Beller G. A., Smith T. W., Abelmann W. H., Haber E., Hood W. B., Jr Digitalis intoxication. A prospective clinical study with serum level correlations. N Engl J Med. 1971 May 6;284(18):989–997. doi: 10.1056/NEJM197105062841801. [DOI] [PubMed] [Google Scholar]
- Davidson C., Gibson D. Clinical significance of positive inotropic action of digoxin in patients with left ventricular disease. Br Heart J. 1973 Sep;35(9):970–976. doi: 10.1136/hrt.35.9.970. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Dobbs S. M. Letter: Starting digoxin. Lancet. 1976 Sep 25;2(7987):694–695. doi: 10.1016/s0140-6736(76)92515-0. [DOI] [PubMed] [Google Scholar]
- Dobbs S. M., Mawer G. E., Rodgers M., Woodcock B. G., Lucas S. B. Can digoxin dose requirements be predicted? Br J Clin Pharmacol. 1976 Apr;3(2):231–237. doi: 10.1111/j.1365-2125.1976.tb00597.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Fogelman A. M., La Mont J. T., Finkelstein S., Rado E., Pearce M. L. Fallibility of plasma-digoxin in differentiating toxic from non-toxic patients. Lancet. 1971 Oct 2;2(7727):727–729. doi: 10.1016/s0140-6736(71)92100-3. [DOI] [PubMed] [Google Scholar]
- KAHLER R. L., THOMPSON R. H., BUSKIRK E. R., FRYE R. L., BRAUNWALD E. Studies on digitalis. VI. Reduction of the oxygen debt after exercise with digoxin in cardiac patients without heart failure. Circulation. 1963 Mar;27:397–405. doi: 10.1161/01.cir.27.3.397. [DOI] [PubMed] [Google Scholar]
- Shapiro W., Narahara K., Taubert K. Relationship of plasma digitoxin and digoxin to cardiac response following intravenous digitalization in man. Circulation. 1970 Dec;42(6):1065–1072. doi: 10.1161/01.cir.42.6.1065. [DOI] [PubMed] [Google Scholar]
- Smith T. W., Haber E. Digoxin intoxication: the relationship of clinical presentation to serum digoxin concentration. J Clin Invest. 1970 Dec;49(12):2377–2386. doi: 10.1172/JCI106457. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Starr I., Luchi R. J. Blind study on the action of digitoxin on elderly women. Am Heart J. 1969 Dec;78(6):740–751. doi: 10.1016/0002-8703(69)90440-2. [DOI] [PubMed] [Google Scholar]
- Wagner J. G., Northam J. I., Alway C. D., Carpenter O. S. Blood levels of drug at the equilibrium state after multiple dosing. Nature. 1965 Sep 18;207(5003):1301–1302. doi: 10.1038/2071301a0. [DOI] [PubMed] [Google Scholar]
- Weissler A. M., Harris W. S., Schoenfeld C. D. Systolic time intervals in heart failure in man. Circulation. 1968 Feb;37(2):149–159. doi: 10.1161/01.cir.37.2.149. [DOI] [PubMed] [Google Scholar]
- Weissler A. M., Schoenfeld C. D. Effect of digitalis on systolic time intervals in heart failure. Am J Med Sci. 1970 Jan;259(1):4–20. doi: 10.1097/00000441-197001000-00002. [DOI] [PubMed] [Google Scholar]